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(I ‘i-15). The development of an implantable atria1 defibrilla- 
tor should therefore be considered in patients with sy 
tomatic recurrent atrial fib~l~ation. 
Although patients may develop sig~i~ca~t symptoms at 
the onset of each episode of paroxysmal trial fibrillation, 
they do remain fully conscious. Acceptability of atrial 
t would therelare be critically dependent 
al waveform. In~~~~ti~~, 
t waveform for the atrium 
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would ~aci~~~a~e a reduction in t 
rovement ofelective tr 
brillators, extensive 
than a monophasic waveform, at prcsenl the most widely 
adopted waveform for defib~l~atio~ of the ventricle inex 
inental and clinical use appears to be biphasic (2%=24). 
report our study corn a bip 
waveform inhuman ep ial aWi 
m The two waveforms were compared in21 pa- 
tients undergoing routine coronary artery bypass grafting 
(14 men, 7 women; mean [rSD] age 62.3 1 7.7 years). The 
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study WAS approved by the hospital ethics committee, and all 
patients gave informed written consent. 
Patients were excluded if 1) they had a left ventricular 
ejection fraction <40% as assessed by contrast ventriculog- 
raphy at the time of cardiac atheterization; 2) they were 
undergoing repeat cardiac surgery; 3) they were undergoing 
concomitant valve replacement; or 4) they had chronic atrial 
fibrillation ( o patient entered in the study had a history of 
either paroxysmal or chronic atrial fibrillation). Patients with 
low ejection fraction were excluded to maintain a more 
uniform study group and to limit any potential risk of a 
n ropic effect on the ventricles from low voltage 
a 
venous pressure and tempera 
ously on a cardiac monitor (He 
from the cardiac monitor was c 
CGs), a~e~al pressure, 
for R wave synchronization of atria1 shocks. An WI3 output 
from the cardiac monitor was also recorded on rna~~et~c tape
tronic model 2394 external cardioverterdefibrihator 
to deliver both the monophasic and the biphasic 
shocks as follows: I) a monophasic truncated exponential, 
8-ms waveform; 2) a biphasic truncated exponential, g-ms, 
dual-capacitor bidirectional waveform with equal first- and 
second-phase duration and leading-edge voltage. Energy for 
the external cardioverter-defibrillator was stored in a series 
of four external capacitors providing atotal capacitance of 
130 fiF. 
The delivered energy of each shock was controlled by 
the leading-edge voltage. For monophasic h the 
iwedge voltage settings were 70, 100, 150. and 
250 V, and for biphasic ks the five leading-edge voltage 
settings were 50, 70, V. One hundred 
shocks were randomiz 0 shocks at each 
vo f both waveforms. 
cardioverter-defibrillator was connected to
atria! defibrillation paddles via a junction box, which pro- 
vided a measurement of the vol and current delivered to 
the patient. The measurements vided by the junction box 
were in the form of two low voltage outputs for recording on 
magnetic tape. The junction box contained a small series 
resistance of 0.5 ohms through which the patient current 
flowed and a high impedance attenuator to reduce the 
defibrillation voltage to <IO V. Output voltages from the 
junction box proportional to the patient’s applied current 
and voltage were connected totwo univerd isolation am- 
plifiers to maintain patient safety. The frequency response of
the amplifiers was direct current (DC) to IO kHz, and their 
Outputs, together with the surface ECG, were recorded at 
two sensitivities on half-inch magnetic tape at a speed of 
fidelity, frequency-modulated, RACAL 
Store 14 recorder with a frequency response ofDC to 20 kHz. 
Because no specific atrial defibrillating paddies or con- 
toured epicardial patches are commercially available, we 
designed atrial paddles from modified pediatric and infant 
contoured ventricular 
tached an 1 l-cm2 cone 
with the anterior 
atrial free walls withou 
c monitor was read 
. Success or failure 
y the investigator and 
of a successful shock (i.e., co sion to sinus rhythm), 
mum of 30 s of established atrial ~bri~~at~o~. 
A~~ys~. After each study the signals tored on magneti:. 
tape (ECC, delivered voltage and delivered current) were 
replayed at a reduced speed of 1% in/s into a Mingograph 
ink jet recorder (Siemens 34T). This gave a paper ecording 
64 times lower than real time and allowed afull bandwidth 
representation of the data. 
The data-recording and playback system was calibrated 
using recordings with dummy resistive loads. A range of 
shocks was delivered across a nd recorded on 
magnetic tape. Printout on the corder allowed 
calibration ofthe recorded voltage and current si 
The leading and trailing edges of the current and voltage 
of each phase of all shocks were measured and entered on a 
data base. The delivered energy of each atrial shock was 
calculated using the formula E = O.SC$VLE’ - VTE2), 
where E = delivered energy, C = capacitance, VLE = 
leading-edge voltage, VTE = trailing-edge voltage. The 
probability of success of the moncphasic and biphasic wave- 
forms was modeled as a function of the delivered energy and 
0.39 (0.36 to 0.38) NS 
v 50 153.8 (46 to 261) 71*9 (6i.9 to 81.9) NS 
V 80 327.9 (I 19 to 537) 86.1 (71.1 to 97.1) < 0.05 
delivered energy and voltage expressed as mean vahres (and 
95% coniidence intervals of the mean). 
The data points and etwee~~ delivered energ 
and percentage of succ I defib~l~atio~ f r eat 
waveform are shown in Figure 1. The biphasic shocks were 
associated with a steep dose-response relation and narrow 
95% confidence intervals of the mean, in contrast to the 
monophasic shocks, which were ed with a shallow 
dose-response curve with wide 9 dence intervals of 
the mean (data scatter). The vdues ivered enesgy and 
“ated with 50% and 8 
basic waveforms a 
was found to he si~~ificaat~y more 
ic wavefo~ at tbe m 
ess (80%). The data on 
delivered voltages and outcomes are given in Table 2. 
Mean and standard error of impedance atthe leading edge 
for all 100 shocks was 52.19 -+ 1.24 ohms. Impedance attbe 
varie 





Voltage Success success 
(VI Outcome (%I Outcome (%I 
44-55 2,‘lO 29% 
3110 30% 3110 3@% 
5110 50% 10110 1 
511 I 4.5% la/lo 1 
168-192 5110 50% 10110 100% 
219-239 919 78% 
Results of 100 randomized atrial shocks. Voltage has been grouped in five 
bands for eack waveform (ranging from 64 to 239 V for tbe mosophasic 
waveform and from 44 to 192 V fur the biphasic waveform), reflecting the 
measured leading-edge voltage of all shocks. Outcome is expressed for each 
waveform as the number of successful shocks over the total number of shocks 
within each voltage band. Success is derived from the corresponding outcome 
for each voltage band. 
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the amplitude of both the first and second phases (26). 
Indeed, at critical values of these three variables certain 
biphsic waveforms can require more energy to defibril!ate 
thar monophasic pulses of equal duration (27). With three 
such interdependent variables the optimal characteristics for 
the ideal biphasic waveform become diticult to determine. 
However, in general itappears that biphasic waveforms are 
most efficient when the duration of the first phase is in the 
region of 4 ms, and the duration of the second phase is less 
than or equal to that of the first phase (28). 
Two recent studies deployed a biphasic 
wavef3rm inatria! &ibrillation in a sheep model. In the 
to be etfective and deliv 
associated with 50% and 
5 and 2.5 J were 
r et al. (31) presented results of a study on 
rms and catheter lectrod 
pace-induced atrial fibrillation i sheep w 
Biphasic waveforms of3 + 3 and 6 + 6 ms in duration we 
compared with monophasic waveforms of 6 and 12 ms 
duration. Biphasic waveforms of 3 + 3 ms in duration were 
found to be most effective and were associated with a 
success rate at a delivered energy of 1.3 J, whereas the 
effective ofthe two monophasic waveforms (6ms) had a 
success rate at 2.2 J, Our study is the first to assess a 
biphasic waveform in atrial defib~liation in humans and is 
consistent with the results of the studies in the sheep model 
“excitation pulse” (31.32); 2) the first phase may shorten 
Ceh refractoriness, enabling more cells to be excited 
second phase (26); 3) the biphasic waveform has a 
lower “upper limit of vulnerability”; i.e., the myocardium is 
less able to reinitiate fibrillation when partially replarized 
(33,34); 4)the first phase opens odium channels on one half 
te (the half nearer the cathode), and the 
ns channels on the other half without 
ose on the first half (thus the energy of the 
second phase becomes critical) (27). 
Of these four proposed mechanisms, that of a “condition- 
ing” effect of the first phase appears to be gaining the most 
suPport; however, whether the mechanism of improved 
efficiency in the atria is identical to that of the ventricles 
remains to be determined. 
~ro~bilistic function of 
that the slope and data 
larger R~mbcr of shocks 
intercept ofthe 
increase in energy reqMirem~~ 
pulmonary bypass (28°C). Of note, we had found in a pilot 
study that atrial fibrillation was more asily maintained after 
20 min of hypothermic cardiopulmonary bypass and a period 
of aortic ross-clamping compared tothe period before or 
immediately after commencing cardiopulmonary bypass. In 
the abzen- of previous tudies on atriai defib~I~atio~ in this 
model it is difficult to determine what effect he combination 
of cardiopu~mon~ bypass, hypothermia, ortic cross- 
clamping and a right atriotomy may have had on the ene 
In previously pMblisbed 
brillation, a “rescue 
shock” has often been used to maintain period of 
ventricular fibrillation before ach study ta avoid 
prolongee hemodynamic embarrassment. I  our study a 
“rescue shock” was not administered to the atria in the case 
of an unsuccessful study shock for the following reasons: 
1) ventricular studies have shown that delaying adefibrillat- 
t receive an im 
atria! defib~llat~on by 
surface area of 
e in a single-chamber implant- 
evice, kctwever, would have 
se~s~~g-~ac~~g kad, which 
ave signal of constant amplitude 
ventricular defibrillation (i.e., a dual-chamber defibrillator). 
The incorporation f an efficient biphasic waveform inan 
implantable atria1 defibrillator device would facilitate a re- 
duction in battery size and an increase in Mery longevity. 
We ~~ate~ul~y acknowledge the statistical advice of Eric Boersma, 
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